393 related articles for article (PubMed ID: 18391624)
1. Advances in nasopharyngeal carcinoma.
Guigay J
Curr Opin Oncol; 2008 May; 20(3):264-9. PubMed ID: 18391624
[TBL] [Abstract][Full Text] [Related]
2. Nasopharyngeal carcinoma with axillary node involvement as a component of failure following chemoradiotherapy.
Lee CM; Hayostek CJ; Abbott TM; Hathaway PB; Watson GA
Ear Nose Throat J; 2005 Mar; 84(3):159-60, 162. PubMed ID: 15871584
[TBL] [Abstract][Full Text] [Related]
3. Concurrent chemoradiotherapy in locally advanced nasopharyngeal carcinoma: a treatment paradigm also applicable to patients in Southeast Asia.
Lu H; Peng L; Yuan X; Hao Y; Lu Z; Chen J; Cheng J; Deng S; Gu J; Pang Q; Qin J
Cancer Treat Rev; 2009 Jun; 35(4):345-53. PubMed ID: 19211192
[TBL] [Abstract][Full Text] [Related]
4. Locoregionally advanced nasopharyngeal carcinoma: induction chemotherapy with cisplatin and 5-fluorouracil followed by radiotherapy and concurrent cisplatin: a phase II study.
Ferrari D; Chiesa F; Codecà C; Calabrese L; Jereczek-Fossa BA; Alterio D; Fiore J; Luciani A; Floriani I; Orecchia R; Foa P
Oncology; 2008; 74(3-4):158-66. PubMed ID: 18714164
[TBL] [Abstract][Full Text] [Related]
5. Treatment approaches to nasopharyngeal carcinoma: a review.
Caponigro F; Longo F; Ionna F; Perri F
Anticancer Drugs; 2010 Jun; 21(5):471-7. PubMed ID: 20124988
[TBL] [Abstract][Full Text] [Related]
6. [Prognostic impact of plasma Epstein-Barr virus DNA concentration on distant metastasis in nasopharyngeal carcinoma].
Hou X; Zhang L; Zhao C; Li S; Lu LX; Han F; Shao JY; Huang PY
Ai Zheng; 2006 Jul; 25(7):785-92. PubMed ID: 16831265
[TBL] [Abstract][Full Text] [Related]
7. Preliminary results of a prospective randomized trial comparing concurrent chemoradiotherapy plus adjuvant chemotherapy with radiotherapy alone in patients with locoregionally advanced nasopharyngeal carcinoma in endemic regions of china.
Chen Y; Liu MZ; Liang SB; Zong JF; Mao YP; Tang LL; Guo Y; Lin AH; Zeng XF; Ma J
Int J Radiat Oncol Biol Phys; 2008 Aug; 71(5):1356-64. PubMed ID: 18472356
[TBL] [Abstract][Full Text] [Related]
8. The prognostic influence of prevertebral space involvement in nasopharyngeal carcinoma.
Lee CC; Chu ST; Chou P; Lee CC; Chen LF
Clin Otolaryngol; 2008 Oct; 33(5):442-9. PubMed ID: 18983377
[TBL] [Abstract][Full Text] [Related]
9. Induction chemotherapy with cisplatin and epirubicin followed by radiotherapy and concurrent cisplatin in locally advanced nasopharyngeal carcinoma observed in a non-endemic population.
Airoldi M; Gabriele AM; Garzaro M; Raimondo L; Condello C; Beatrice F; Pecorari G; Giordano C
Radiother Oncol; 2009 Jul; 92(1):105-10. PubMed ID: 19264368
[TBL] [Abstract][Full Text] [Related]
10. Review of nasopharyngeal carcinoma.
Jeyakumar A; Brickman TM; Jeyakumar A; Doerr T
Ear Nose Throat J; 2006 Mar; 85(3):168-70, 172-3, 184. PubMed ID: 16615599
[TBL] [Abstract][Full Text] [Related]
11. [Nasopharyngeal carcinomas: from biology to clinic].
Rivera S; Keryer C; Busson P; Maingon P
Cancer Radiother; 2005 Feb; 9(1):55-68. PubMed ID: 15804621
[TBL] [Abstract][Full Text] [Related]
12. Can plasma Epstein-Barr virus DNA levels be used to monitor nasopharyngeal carcinoma progression?
Farrell PJ
Nat Clin Pract Oncol; 2005 Jan; 2(1):14-5. PubMed ID: 16264847
[No Abstract] [Full Text] [Related]
13. Metronomic adjuvant chemotherapy improves treatment outcome in nasopharyngeal carcinoma patients with postradiation persistently detectable plasma Epstein-Barr virus deoxyribonucleic acid.
Twu CW; Wang WY; Chen CC; Liang KL; Jiang RS; Wu CT; Shih YT; Lin PJ; Liu YC; Lin JC
Int J Radiat Oncol Biol Phys; 2014 May; 89(1):21-9. PubMed ID: 24725686
[TBL] [Abstract][Full Text] [Related]
14. Correlation of Epstein-Barr virus DNA in cell-free plasma, functional imaging and clinical course in locally advanced nasopharyngeal cancer: a pilot study.
Mäkitie AA; Reis PP; Irish J; Zhang T; Chin SF; Chen X; Marriott C; Keller A; Perez-Ordonez B; Kamel-Reid S; Siu LL
Head Neck; 2004 Sep; 26(9):815-22. PubMed ID: 15350028
[TBL] [Abstract][Full Text] [Related]
15. Nasopharyngeal carcinoma: the impact of CT-scan and of MRI on staging, radiotherapy treatment planning, and outcome of the disease.
Manavis J; Sivridis L; Koukourakis MI
Clin Imaging; 2005; 29(2):128-33. PubMed ID: 15752969
[TBL] [Abstract][Full Text] [Related]
16. Progress and controversy for the role of chemotherapy in nasopharyngeal carcinoma.
Yoshizaki T; Kondo S; Murono S; Endo K; Tsuji A; Nakanishi Y; Nakanishi S; Sugimoto H; Hatano M; Ueno T; Wakisaka N
Jpn J Clin Oncol; 2015 Mar; 45(3):244-7. PubMed ID: 25583421
[TBL] [Abstract][Full Text] [Related]
17. Significance of primary tumor volume and T-stage on prognosis in nasopharyngeal carcinoma treated with intensity-modulated radiation therapy.
Chen C; Fei Z; Pan J; Bai P; Chen L
Jpn J Clin Oncol; 2011 Apr; 41(4):537-42. PubMed ID: 21242183
[TBL] [Abstract][Full Text] [Related]
18. Systemic treatment strategies and therapeutic monitoring for advanced nasopharyngeal carcinoma.
Ma BB; Chan AT
Expert Rev Anticancer Ther; 2006 Mar; 6(3):383-94. PubMed ID: 16503855
[TBL] [Abstract][Full Text] [Related]
19. Modern treatment for nasopharyngeal carcinoma: current status and prospects.
Rottey S; Madani I; Deron P; Van Belle S
Curr Opin Oncol; 2011 May; 23(3):254-8. PubMed ID: 21330921
[TBL] [Abstract][Full Text] [Related]
20. Concurrent chemoradiotherapy with adjuvant chemotherapy for high-risk nasopharyngeal carcinoma.
Lee CC; Chu ST; Chou P
Auris Nasus Larynx; 2009 Dec; 36(6):688-94. PubMed ID: 19410399
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
